SOLIGENIX, INC. — Director's Dealing 2009

Mar 16, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-03-10

Reporting Person: Lapointe Gregg Anthony (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-03-10	Stock Options (right to buy)	$.11	A	300000	Acquired	2019-03-09	Common Stock (300000)	Direct

Footnotes

F1: As a new Board member, the Company granted Mr. Lapointe options to purchase 300,000 shares of the Company?s common stock at a strike price of $0.11 with an expiration date of March 9, 2019. All options vested on March 10, 2009.